

The Precision Medicine deal market is one of the most active and dynamic in the Life Sciences industry. Our Precision Medicine team provides clients with end-to-end deal support, from deal strategy, target identification and prioritization, commercial, financial and operational diligence, to execution for acquisitions, mergers, and divestitures and post-deal value capture. Our practice has been on the buy- and sell-side for deals in the Precision Medicine ecosystem for both corporate and private entities.
To understand more about how we support our corporate and private investors with our full-suite of deal services please contact us.
Visit the KPMG in Precision Medicine page